Global Parenteral Nutrition Market is valued approximately USD 5.9 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 5.50% over the forecast period 2021-2027. Parenteral nutrition is feeding nutrition in the body intravenously to a person who cannot eat or absorb enough food through mouth or tube feeding formula. The nutrition generally includes protein, carbohydrate, fat, minerals, electrolytes and vitamins. The increasing cases of malnutrition among children as well as the rising incidences of pre-mature birth of babies is propelling the market of parenteral nutrition. Above mentioned factors, coupled with the rising geriatric population which need nutritional support, are driving the Parenteral Nutrition market.
The increasing cases of chronic illness such as cancer has increased the usage of parenteral nutrition too. According to UNICEF, almost half of all deaths in children under 5 are due to undernutrition. These mostly occur in low and middle-income countries. Undernutrition puts children at risk of dying from common infections and increases the frequency and severity of such infections, with delayed recovery in many cases. World health organization reported that nearly 1.9 billion adults are overweight or obese, while 462 million are underweight in 2020. One of the sustainable development goals of UN is to end all forms of malnutrition by 2030, which will help in growth of parenteral nutrition market. However, there is a greater risk of infection while taking nutrients parenterally. This issue may act as a restraint for its growth. On the other hand, increasing governmental support in the form of policies and fund for ending the malnutrition problem acts as an opportunity for Parenteral Nutrition Market in subsequent decade.

Key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World are analysed to provide a holistic picture of Parenteral Nutrition Market. Due to higher expenditure on healthcare industry as well as higher per capita income, North America has emerged as the significant region across the world in terms of market share. Whereas, Asia-Pacific is expected to exhibit highest growth rate for the forecast period 2021-2027 owing to the growing population in the region. Rising disposable income and growing incidences of chronic illness including cancer will also boost growth in this region.

Major market player included in this report are:
B. Braun Melsungen AG
Fresenius Kabi AG
Allergan Plc
Grifols, S.A.
Pfizer, Inc. (Hospira)
Otsuka Pharmaceutical Factory, Inc.
Baxter International, Inc.
Sichuan Kelun Pharmaceutical Co., Ltd
Vifor Pharma
Aculife (Nirlife)

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Nutrient Type:
Parenteral Lipid Emulsion
Single Dose Amino Acid Solution
Trace Elements
Vitamins & Minerals

By Region:
North America

Asia Pacific
South Korea
Latin America
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027

Target Audience of the Global Parenteral Nutrition Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers